HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena Kovalenko Selected Research

Therapeutics

10/2018Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena Kovalenko Research Topics

Disease

1Adult Type Lactose Intolerance
01/2023
1Lactose Intolerance (Intolerance, Lactose)
01/2023
1Brain Neoplasms (Brain Tumor)
12/2019
1Neoplasms (Cancer)
12/2019
1Glioblastoma (Glioblastoma Multiforme)
12/2019
1Breast Neoplasms (Breast Cancer)
10/2018
1Autoimmune Diseases (Autoimmune Disease)
10/2015
1Rheumatoid Arthritis
10/2015

Drug/Important Bio-Agent (IBA)

1LactaseIBA
01/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019
1ErbB Receptors (EGF Receptor)IBA
10/2018
1EverolimusFDA Link
10/2018
1Capecitabine (Xeloda)FDA Link
10/2018
1Aromatase InhibitorsIBA
10/2018
1exemestane (Aromasin)FDA Link
10/2018
1Estrogen ReceptorsIBA
10/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2015

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2019
1Therapeutics
10/2018